Research Articles | Page 96 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)
Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis Dec 2019 Leukemia myelodysplastic syndromes (MDS)
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients Feb 2013 Leukemia myelodysplastic syndromes (MDS)
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system Oct 2015 Leukemia myelodysplastic syndromes (MDS)
What causes aplastic anaemia? Apr 2023 Leukemia aplastic anemia
Long-term outcome of anemic lower-risk myelodysplastic syndromes without 5q deletion refractory to or relapsing after erythropoiesis-stimulating agents Jan 2013 Leukemia myelodysplastic syndromes (MDS)
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials Oct 2016 Leukemia myelodysplastic syndromes (MDS)
Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes Aug 2017 Leukemia
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides Oct 2015 Leukemia
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Jan 2019 Leukemia myelodysplastic syndromes (MDS)
Share with addtoany.com.